NCT07760285

Brief Summary

Worldwide accelerated advances in physical rehabilitation of chronic kidney disease; particularly whom undergoing hemodialysis. Multimodal therapeutic approaches may maximize their recovery through preliminary evidence indicating both intradialytic neuromuscular electrical stimulation or Virtual reality-based rehabilitation (VRBR) is a relatively new method that might make it easier to simulate doing functional tasks than conventional rehabilitation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

August 7, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
Last Updated

August 12, 2026

Status Verified

August 1, 2026

Enrollment Period

6 months

First QC Date

August 7, 2026

Last Update Submit

August 7, 2026

Conditions

Keywords

Digital goniometershoulder dysfunctionshoulder pain and disability indexVirtual realityChronic kidney diseaseDynamometerRenin HormoneIntradialytic neuromuscular electrical stimulationMaitland Mobilization

Outcome Measures

Primary Outcomes (1)

  • Renin Hormone test

    SIEMENS, Blood Analyzer, Model: DCA Vantage, MPN: 4.6.0.0, USA; Hemostasis system equipment is manufactured by Siemens manumitted company, Germany for both renin hormone test and glomerular filtration rate monitoring among CKD patients collected samples early morning by responsible nursing staff from renal vein through the already inserted catheter/ or directly from patients' veins

    At pretreatment At post treatment after 8 weeks of the study protocol

Secondary Outcomes (3)

  • Shoulder Range of Motion

    At pretreatment At posttreatment after 8 weeks of the study protocol

  • Shoulder muscular strength

    At pretreatment At posttreatment after 8 weeks of study protocol

  • The shoulder pain intensity and functional disability assessment

    At pretreatment At posttreatment of 8 weeks of the study protocol

Study Arms (3)

Experimental Group A (Virtual reality)

EXPERIMENTAL

20 participants suffering from CKD received Virtual reality by Xbox Kinect 360 console, plus conventional physical therapy protocol, along 8 weeks

Other: Virtual Reality sessionOther: Conventional Physical Therapy protocol

Experimental Group B (intradialytic neuromuscular electrical stimulation )

EXPERIMENTAL

20 participants suffering from CKD received intradialytic neuromuscular electrical stimulation protocol, for 30 minutes, 3 times per week over 8 weeks.

Other: intradialytic neuromuscular electrical stimulationOther: Conventional Physical Therapy protocol

Experimental Group A (conventional physical therapy protocol including Maitland mobilization)

EXPERIMENTAL

20 participants suffering from CKD received Maitland mobilization, plus Conventional physical therapy protocol, along 30-40 minutes, 3 sets/ week over 8 weeks.

Other: Maitland MobilizationOther: Conventional Physical Therapy protocol

Interventions

virtual reality exercise programs that was applied in form of a series of kinect adventure games and designed for Xbox 360 kinect console, and projected onto a 24-inch screen LED-Lit monitor; along 30-40 min, 3 sets/ week along 8 weeks

Experimental Group A (Virtual reality)

The portable Chattanooga electric stimulation device has been switched on and adjusted the current amplitude/ strength from 5-140 mA according to each patients' targeted strength, frequency seated at 5Hz over shoulder musculatures under direct supervision along 30 minutes for each session, 3 sessions per week over 8 weeks

Experimental Group B (intradialytic neuromuscular electrical stimulation )

maitland graded oscillation technique that was applied to the glenohumeral (GH) joint in form of anteroposterior (A-P), posteroanterior (P-A), and longitudinal caudal glides; as well regarding sternoclavicular joint 'Posterior and anterior glide', plus acromioclavicular joint; anterior glide, only fifteen glides, along 30-40 min, 3 sets/ week along 8 weeks

Experimental Group A (conventional physical therapy protocol including Maitland mobilization)

Active range of motion exercises; along 30-40 min, 3 sets/ week along 8 weeks

Experimental Group A (Virtual reality)Experimental Group A (conventional physical therapy protocol including Maitland mobilization)Experimental Group B (intradialytic neuromuscular electrical stimulation )

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient underwent modified radical mastectomy from one month earlier, suffering from shoulder pain and limited range of motion were included in current study.
  • Patients' age ranged from 40 to 65 years. Patients of both genders. All patients were free of any comorbidities such as systemic or neurological diseases.

You may not qualify if:

  • Patient underwent modified radical mastectomy from one month earlier, suffering from shoulder pain and limited range of motion were included in current study.
  • Patients' age ranged from 40 to 65 years. Patients of both genders. All patients were free of any comorbidities such as systemic or neurological diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shebin ElKom Teaching Hospital

Cairo, Menofyia, 11432, Egypt

Location

MeSH Terms

Conditions

Renal Insufficiency, ChronicBursitisShoulder Pain

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsJoint DiseasesMusculoskeletal DiseasesArthralgiaPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Randomized conducted via computerized 'version 25; SPSS Inc., Chicago, Illinois, USA". Each had 1 defining record to assign him/ her into triple equal groups, later were indexing cards in opaque envelopes. Thus,
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, randomized, controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Physical Therapy Specialist

Study Record Dates

First Submitted

August 7, 2026

First Posted

August 12, 2026

Study Start

January 1, 2026

Primary Completion

July 1, 2026

Study Completion

August 1, 2026

Last Updated

August 12, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations